Esprotis L Capsule SR is a combination medication containing Levosulpiride 75mg and Esomeprazole 40mg, formulated to provide effective relief from gastrointestinal disorders. Levosulpiride is a prokinetic agent that enhances gastric motility by blocking dopamine receptors, thereby improving symptoms such as nausea, vomiting, bloating, and abdominal discomfort associated with delayed gastric emptying and functional dyspepsia. Esomeprazole, a proton pump inhibitor, reduces gastric acid secretion by inhibiting the H+/K+ ATPase enzyme system in the stomach lining, promoting healing of acid-related conditions such as gastroesophageal reflux disease (GERD), erosive esophagitis, and peptic ulcers. The sustained-release formulation ensures a gradual and prolonged release of the active ingredients, providing extended symptom control and improved patient compliance. Esprotis L Capsule SR is commonly prescribed for patients suffering from combined motility and acid-related gastrointestinal disorders, offering dual action to alleviate symptoms and promote mucosal healing. It should be taken as directed by a healthcare professional, and patients are advised to report any adverse effects such as headache, dizziness, or allergic reactions. This medication is not recommended for individuals with known hypersensitivity to its components or those with certain pre-existing conditions without medical supervision.